Nevan Krogan | |
---|---|
Academic background | |
Education | University of Regina University of Toronto |
Thesis | Protein complexes and epistatic mini-array profiles (E-MAPs) reveal pathways involved in chromatin function (2006) |
Doctoral advisor | Jack Greenblatt |
Academic work | |
Institutions | University of California San Francisco (UCSF) J. David Gladstone Institutes |
Nevan J. Krogan is a Canadian molecular and systems biologist. [1] He is a professor and the Director of the Quantitative Biosciences Institute (QBI) at the University of California San Francisco (UCSF),as well as a senior investigator at the J. David Gladstone Institutes. [2]
Krogan’s research focuses on developing and using unbiased,quantitative systems approaches to study a wide variety of diseases with the ultimate goal of developing new therapeutics. He has authored over 350 papers in the field of molecular biology and has given over 400 lectures and seminars around the world.
Krogan was born in Regina,Saskatchewan,Canada. He obtained his undergraduate degree in chemistry in 1997 and his M.Sc. in biology in 1999 from the University of Regina. Krogan received his Ph.D. in medical genetics at the University of Toronto in 2006 with Jack Greenblatt as his doctoral advisor. During his PhD,he explored the combination of protein-protein and genetic interaction data sets. [3] [4]
Krogan became a Sandler Fellow in 2006 at UCSF,an assistant professor in 2007,and a full professor in 2011. He also became an investigator at the Gladstone Institutes in 2011. [5] He was appointed director of the Quantitative Biosciences Institutes at UCSF in March 2016. [6]
Krogan serves as Director of The HARC Center,an NIH-funded collaborative group that focuses on the structural characterization of HIV-human protein complexes. Krogan is also the co-Director of three Cell Mapping initiatives,the Cancer Cell Mapping Initiative (CCMI), [7] the Host Pathogen Map Initiative (HPMI) [8] and the Psychiatric Cell Map Initiative (PCMI). [9] These initiatives map the gene and protein networks in healthy and diseased cells with these maps being used to better understand disease and provide novel therapies to fight them.
In 2020,Krogan led the work to create the SARS-CoV-2 interactome and assembled the QBI Coronavirus Research Group (QCRG) to study SARS-CoV-2 and to find treatments for Covid-19. [10]
Krogan co-established the Institut Pasteur-UCSF Quantitative Biosciences Institute (QBI) Center of Excellence in Emerging Infectious Diseases,a partnership between the University of California,San Francisco (UCSF),and the Institut Pasteur in Paris,France. [11] The Center focuses on pandemic preparedness as well as the prediction and treatment of emerging infectious diseases. [12] [13]
In 2022,Krogan co-founded Rezo Therapeutics,a biotechnology company focused on the integrated mapping of disease networks for precision therapeutics. [14] Rezo Therapeutics is located in the Bay Area and is based on technology from QBI at UCSF. [15]
In 2021,Krogan contributed $2.08 million to the University of Regina,the largest donation in the university’s history,in order to help ten Haitian students attend post-secondary in Regina. For this,he has worked alongside the Children of Haiti Project. [16]
Carolyn Ruth Bertozzi is an American chemist and Nobel laureate,known for her wide-ranging work spanning both chemistry and biology. She coined the term "bioorthogonal chemistry" for chemical reactions compatible with living systems. Her recent efforts include synthesis of chemical tools to study cell surface sugars called glycans and how they affect diseases such as cancer,inflammation,and viral infections like COVID-19. At Stanford University,she holds the Anne T. and Robert M. Bass Professorship in the School of Humanities and Sciences. Bertozzi is also an Investigator at the Howard Hughes Medical Institute (HHMI) and is the former director of the Molecular Foundry,a nanoscience research center at Lawrence Berkeley National Laboratory.
The California Institute for Quantitative Biosciences (QB3) is a nonprofit research and technology commercialization institute affiliated with three University of California campuses in the San Francisco Bay Area:Berkeley,San Francisco,and Santa Cruz. QB3's domain is the quantitative biosciences:areas of biology in which advances are chiefly made by scientists applying techniques from physics,chemistry,engineering,and computer science.
Philippe J. Sansonetti is a French microbiologist,professor at the Pasteur Institute and the Collège de France in Paris. He is the director of the Inserm Unit 786 and of the Institut Pasteur laboratory Pathogénie Microbienne Moléculaire.
Dorothee Kern,is a professor of Biochemistry at Brandeis University and former player for the East German national basketball team.
Gladstone Institutes is an American independent,non-profit biomedical research organization whose focus is to better understand,prevent,treat and cure cardiovascular,viral and neurological conditions such as heart failure,HIV/AIDS and Alzheimer's disease. Its researchers study these diseases using techniques of basic and translational science. Another focus at Gladstone is building on the development of induced pluripotent stem cell technology by one of its investigators,2012 Nobel Laureate Shinya Yamanaka,to improve drug discovery,personalized medicine and tissue regeneration.
Dundee Cell Products (DCP) is a biotechnology company headquartered in Dundee,Scotland,United Kingdom.
Regis Baker Kelly OBE is a neuroscientist and university administrator who develops academia-industry partnerships and supports early-stage entrepreneurship in the life sciences.
Diane L. Barber is an American cell biologist. She is an Endowed Professor and Chair of the Department of Cell and Tissue Biology at University of California,San Francisco (UCSF) and an elected American Association for the Advancement of Science fellow in recognition of her "distinguished contributions on cell signaling by plasma membrane ion transport proteins and on the design and function of proteins regulated by intracellular pH dynamics." In addition to teaching graduate and professional students and her administrative service,she directs a research laboratory funded by grants from the National Institutes of Health (NIH) and the National Science Foundation (NSF).
Jennifer Anne Doudna is an American biochemist who has pioneered work in CRISPR gene editing,and made other fundamental contributions in biochemistry and genetics. She received the 2020 Nobel Prize in Chemistry,with Emmanuelle Charpentier,"for the development of a method for genome editing." She is the Li Ka Shing Chancellor's Chair Professor in the department of chemistry and the department of molecular and cell biology at the University of California,Berkeley. She has been an investigator with the Howard Hughes Medical Institute since 1997.
The Quantitative Biology Center (QBiC) is a Strategic Research Center of the Japanese national research and development institute,Riken. In November 2014,they succeeded in making a translucent mouse in order to see its internal organs more clearly.
Eric M. Verdin is a Belgian geroscientist,researcher,and professor who has served as President and chief executive officer of the Buck Institute for Research on Aging since 2016. Verdin’s research focuses on metabolism,diet,and the different proteins and molecules that affect the aging process and its associated diseases. He has published more than 210 papers and has more than 15 patents.
The Queensland Brain Institute (QBI) is an Australian neuroscience research institute,located in Brisbane at the St Lucia campus of The University of Queensland (UQ). Founding director Professor Perry Bartlett established the QBI in 2003 with assistance from The University of Queensland,Queensland State Government,and Chuck Feeney,founder of The Atlantic Philanthropies. The purpose-built facility was commissioned in 2004 and on 19 November 2007,the building was opened by former Queensland Premier Anna Bligh.
Carole LaBonne is a Developmental and Stem Cell Biologist at Northwestern University. She is the Erastus Otis Haven Professor of Molecular Biosciences and president of the Society for Developmental Biology.
Anne Bertolotti is a French biochemist and cell biologist who works as Programme Leader at the MRC Laboratory of Molecular Biology in Cambridge,UK. In 2022 she was appointed Head of the MRC LMB's Neurobiology Division. She is known for her research into the cellular defences against misfolded proteins and the mechanisms underlying their deposition,the molecular problem causative of neurodegenerative diseases.
Katerina Akassoglou is a neuroimmunologist who is a Senior Investigator and Director of In Vivo Imaging Research at the Gladstone Institutes. Akassoglou holds faculty positions as a Professor of Neurology at the University of California,San Francisco. Akassoglou has pioneered investigations of blood-brain barrier integrity and development of neurological diseases. She found that compromised blood-brain barrier integrity leads to fibrinogen leakage into the brain inducing neurodegeneration. Akassoglou is internationally recognized for her scientific discoveries.
Robert V. Farese,Jr., is an American physician-scientist and professor of Cell Biology at the Sloan Kettering Institute of Memorial Sloan Kettering. He is an internationally recognized leader in the study of cellular lipid metabolism and has made seminal contributions to our understanding of energy storage as triglycerides in cellular organelles called lipid droplets.
Seth Shipman is an American scientist. Shipman is an assistant professor at the Gladstone Institutes and the University of California,San Francisco,where he researches synthetic biology,genetics,and neuroscience.
The Quantitative Biosciences Institute (QBI) was established in 2016 as an organized research unit (ORU) within the School of Pharmacy at the University of California-San Francisco. The current director of QBI is Nevan Krogan.
Danica GalonićFujimori is a Serbian-American chemical biologist who is a professor at the University of California,San Francisco. Her research considers nucleic acid synthesis and tissue engineering. In the search for new therapeutics and vaccines,she has studied the interactions between ribosomes and SARS-CoV-2.
The Innovative Genomics Institute (IGI) is an American nonprofit scientific research institute founded by Nobel laureate and CRISPR gene editing pioneer Jennifer Doudna and biophysicist Jonathan Weissman. The institute is based at the University of California,Berkeley,and also has member researchers at the University of California,San Francisco,UC Davis,UCLA,Lawrence Berkeley National Laboratory,Lawrence Livermore National Laboratory,Gladstone Institutes,and other collaborating research institutions. The IGI focuses on developing real-world applications of genome editing to address problems in human health,agriculture and climate change.